ScoreWhy is Sun Pharmaceutical Industries Ltd ?
1
Low Debt Company with Strong Long Term Fundamental Strength
- Healthy long term growth as Net Sales has grown by an annual rate of 11.37% and Operating profit at 20.79%
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 15.21% signifying high profitability per unit of shareholders funds
2
High Institutional Holdings at 37.04%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
3
Consistent Returns over the last 3 years
- Along with generating 8.64% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
4
With its market cap of Rs 4,42,725 cr, it is the biggest company in the sector and constitutes 17.19% of the entire sector
- Its annual Sales of Rs 56,809.09 are 11.75% of the industry
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Sun Pharma.Inds. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Sun Pharma.Inds. for you?
Low Risk, High Return
Absolute
Risk Adjusted
Volatility
Sun Pharma.Inds.
8.93%
0.44
19.60%
Sensex
-6.64%
-0.51
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
11.37%
EBIT Growth (5y)
20.79%
EBIT to Interest (avg)
55.35
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
-0.29
Sales to Capital Employed (avg)
0.71
Tax Ratio
25.78%
Dividend Payout Ratio
35.13%
Pledged Shares
1.42%
Institutional Holding
37.04%
ROCE (avg)
21.14%
ROE (avg)
15.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
34
Price to Book Value
5.69
EV to EBIT
28.64
EV to EBITDA
24.01
EV to Capital Employed
7.62
EV to Sales
7.39
PEG Ratio
12.37
Dividend Yield
0.89%
ROCE (Latest)
25.07%
ROE (Latest)
14.84%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NO KEY POSITIVE TRIGGERS
-5What is not working for the Company
PBT LESS OI(Q)
At Rs 3,092.84 cr has Fallen at -13.9% (vs previous 4Q average
PAT(Q)
At Rs 2,714.03 cr has Fallen at -10.6% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is not working for Sun Pharma.Inds.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 3,092.84 cr has Fallen at -13.9% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 3,591.24 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 2,714.03 cr has Fallen at -10.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 3,035.72 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
